Umeclidinium Bromide
CAS 869113-09-7
Overview
Umeclidinium bromide, sold under the brand name Incruse Ellipta, is a long-acting muscarinic antagonist approved for the maintenance treatment of chronic obstructive pulmonary disease
Anant Labs manufacture and furnish high quality Umeclidinium Bromide impurities for global markets. Our Umeclidinium Bromide EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
Cat. No.ANT-UMD-00
CAS869113-09-7
Mol. FormulaC29H34BrNO2
Mol. Weight508.5 g/mol
IUPACdiphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol bromide
SMILESC1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5.[Br-]
InChIInChI=1S/C29H34NO2.BrH/c31-29(26-12-6-2-7-13-26,27-14-8-3-9-15-27)28-16-19-30(20-17-28,21-18-28)22-23-32-24-25-10-4-1-5-11-25;/h1-15,31H,16-24H2;1H/q+1;/p-1
InChI KeyPEJHHXHHNGORMP-UHFFFAOYSA-M
Note: We are upgrading our system, Cat No will change.
Synonyms
4-(Hydroxydiphenylmethyl)-1-[2-[(phenylmethyl)oxy]ethyl]-1-azabicyclo[2.2.2]octanium bromideUmeclidinium bromide869113-09-7Incruse ElliptaAnoro Ellipta1-[2-(Benzyloxy)ethyl]-4-(hydroxydiphenylmethyl)-1-quinuclidinium BromideGSK573719AGSK-573719AMFCD27976798bromure d'umeclidinium
